Skip to content

Prevalence of Inflammatory Bowel Disease in Patients With Perianal Disease

Prevalence of Inflammatory Bowel Disease in Patients With Perianal Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00972088
Enrollment
26
Registered
2009-09-04
Start date
2008-08-31
Completion date
2011-06-30
Last updated
2013-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Disease, Perianal Abscess, Perianal Fistula

Keywords

inflammation of the small bowel

Brief summary

To show that prevalence of inflammation of the small bowel in patients with anorectal disease is under-diagnosed based on colonoscopy ileoscopy alone.

Detailed description

IBD of the small bowel is associated with perianal disease such as ano-rectal abscesses and fistulas. Colonoscopy with ileoscopy and small bowel series are relied upon to document the presence of Crohn's disease of the small bowel. We suspect that the prevalence of inflammatory small bowel disease is underestimated. In my practice I have cases that had negative colonoscopy ileoscopy and positive findings at capsule endoscopy. These patients are receiving therapy for Crohn's disease. It is important to prove that the prevalence is higher. Capsule Endoscopy (CE) is the first line tool diagnostic procedure for the examination of the small bowel. It is performed today in more than 2,900 GI clinics in hospitals, outpatient departments and physicians' offices all over the world using the PillCam® Platform. Over 500,000 CE procedures with the Given PillCam SB have been completed to date.

Interventions

DEVICEcapsule endoscopy

The disposable, ingestible PillCam® SB2 Capsule acquires the video images during natural propulsion through the digestive system. The Capsule transmits the acquired images via digital radio frequency communication channel to the Given® Data Recorder unit located outside the body.

Sponsors

Bikkur Holim Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients between the ages of 10 - 80 * Patients with anorectal abscess of anorectal fistula * Patient is male or female * Within three months prior to enrollment, patient has normal test results for at least one of the following tests: 1. Colonoscopy with Ileoscopy, and/or 2. Colonoscopy with small bowel series, and/or 3. Colonoscopy with CT enterography * Within three months prior to enrollment patient has the following lab tests: Blood count, sedimentation rate, CRP. IBD serology is optional. * Sign informed consent

Exclusion criteria

* Can not sign informed consent * Contraindications to colonoscopy ileoscopy or capsule endoscopy * History of established IBD

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of Inflammation as Diagnosed by Capsule Endoscopyup to 7 daysThe capsule endoscopy findings were carefully examined by specialists in the field. findings such as erosions, edema, erythema and ulceration in significant areas of the intestine led to the clinical diagnosis of crohn's disease. all together 6 patients were diagnosed as suffering from crohn's disease.

Countries

Israel

Participant flow

Recruitment details

from 2009 until june 2011 26 patients were enrolled from gastroenterology clinics

Pre-assignment details

patients were enrolled to undergo capsule endoscopy of the small bowel if they had perianal disease and a negative colonoscopy with ileoscopy or a negative colonoscopy with a negative small bowel series or negative ct enterography

Participants by arm

ArmCount
Anorectal Disease, Negative Work up for Crohns Disease
Patients presently suffering from anorectal abscess or anorectal fistula
26
Total26

Baseline characteristics

CharacteristicAnorectal Disease, Negative Work up for Crohns Disease
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
26 Participants
Age Continuous34.3 years
STANDARD_DEVIATION 12.6
Region of Enrollment
Israel
26 participants
Sex: Female, Male
Female
9 Participants
Sex: Female, Male
Male
17 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 26
serious
Total, serious adverse events
0 / 26

Outcome results

Primary

Prevalence of Inflammation as Diagnosed by Capsule Endoscopy

The capsule endoscopy findings were carefully examined by specialists in the field. findings such as erosions, edema, erythema and ulceration in significant areas of the intestine led to the clinical diagnosis of crohn's disease. all together 6 patients were diagnosed as suffering from crohn's disease.

Time frame: up to 7 days

Population: per protocol

ArmMeasureValue (NUMBER)
Anorectal Disease, Negative Work up for Crohns DiseasePrevalence of Inflammation as Diagnosed by Capsule Endoscopy6 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026